OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 41.18 percent. This is a 300 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $148.500 million which beat the analyst consensus estimate of $139.757 million by 6.26 percent. This is a 19.12 percent decrease over sales of $183.600 million the same period last year.